Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ONCOSYNE AS
AS
Active
Org 926191942
Ullernchausséen 64, 0379
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2020 · 5 years old
6 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ONCOSYNE AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
1M
2M
3M
5M
0M
2020
0M
2021
1M
2022
2M
2023
4M
2024
EBITDA
NOK millions
0M
-1M
-2M
-3M
-4M
0M
2020
0M
0%
2021
-1M
-100%
2022
-3M
-200%
2023
-2M
+33%
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
450
1 450
1 657
4 380
Staff expenses
−0
−0
−1 034
−2 200
−2 688
EBITDA
0
−202
−1 252
−3 169
−1 854
Depreciation & amort.
−0
−0
−40
−18
−127
EBIT
0
−202
−1 292
−3 187
−1 981
Net financials
0
6
11
46
260
Profit before tax
0
−196
−1 281
−3 141
−1 721
Tax
−0
−0
−0
−0
−0
Net profit
0
−196
−1 281
−3 141
−1 721
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
500
804
4 914
5 803
11 964
Equity
494
619
4 338
5 197
10 762
Long-term debt
0
0
0
0
0
Short-term debt
6
186
576
606
1 202
Total debt
6
186
576
606
1 202
Financial ratios
5-year trend
EBITDA margin
-42.3%
This company
15.8%
Market median
-368% vs market
2020
2024
Equity ratio
90.0%
This company
38.2%
Market median
+136% vs market
2020
2024
Return on equity
-16.0%
This company
18.4%
Market median
-187% vs market
2020
2024
Net profit margin
-39.3%
This company
8.1%
Market median
-585% vs market
2020
2024
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
2020
2024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on ONCOSYNE AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
